Corrigendum: Comparison of prognosis between microscopically positive and negative surgical margins for primary gastrointestinal stromal tumors: A systematic review and meta-analysis

Corrigendum: Comparison of prognosis between microscopically positive and negative surgical margins for primary gastrointestinal stromal tumors: A systematic review and meta-analysis

Bibliographic Details
Main Authors:	Zhen Liu, Yichunzi Zhang, Han Yin, Xiuzhu Geng, Sishang Li, Jinrong Zhao, Ziyang Zeng, Xin Ye, Jianchun Yu, Fan Feng, Weiming Kang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2023-01-01
Series:	Frontiers in Oncology
Subjects:	gastrointestinal stromal tumor R1 margin Imatinib prognosis meta-analysis
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2022.1110168/full

Similar Items

Comparison of Prognosis Between Microscopically Positive and Negative Surgical Margins for Primary Gastrointestinal Stromal Tumors: A Systematic Review and Meta-Analysis
by: Zhen Liu, et al.
Published: (2022-04-01)

Massive gastrointestinal stromal tumor of stomach mimicking a uterine leiomyoma
by: Keyur S Gutte
Published: (2012-01-01)

A gist on an obscure neoplasm in Ghana: gastrointestinal stromal tumours
by: Joseph Yorke, et al.
Published: (2023-11-01)

Interpretation of Pathologic Margin after Endoscopic Resection of Gastrointestinal Stromal Tumor
by: Sang Gyun Kim
Published: (2016-05-01)

Surgical intervention of a giant gastric gastrointestinal stromal tumor following neoadjuvant therapy with imatinib
by: Chien-Yang Wang, et al.
Published: (2018-01-01)

Successful Endoscopic Resection of a Rectal Gastrointestinal Stromal Tumor Larger Than 5 cm
by: Seong Jung Kim, et al.
Published: (2021-10-01)

Diagnosis and management of high risk gastrointestinal stromal tumor in first trimester pregnancy: A case report and review of the literature
by: Christina M. Sheedy, et al.
Published: (2023-05-01)

Surgical Approaches and Oncological Outcomes in the Management of Duodenal Gastrointestinal Stromal Tumors (GIST)
by: Nikolaos Vassos, et al.
Published: (2021-09-01)

Preoperative imatinib for patients with primary unresectable or metastatic/recurrent gastrointestinal stromal tumor
by: Chaoyong Shen, et al.
Published: (2014-11-01)

The choice of treatment method in patients with complicated gastrointestinal stromal tumors. Clinical observation and literature review
by: S N Nered, et al.
Published: (2017-01-01)

Advances in the research of the mechanism of secondary resistance to imatinib in gastrointestinal stromal tumors
by: Xiangchen Hu, et al.
Published: (2022-09-01)

Gastrointestinal stromal tumours in patients presenting to an academic hospital in South Africa
by: Barbara M. Robertson, et al.
Published: (2023-06-01)

Heterogeneity of Metabolic Vulnerability in Imatinib-Resistant Gastrointestinal Stromal Tumor
by: Wen-Kuan Huang, et al.
Published: (2020-05-01)

Collision tumour involving a rectal gastrointestinal stromal tumour with invasion of the prostate and a prostatic adenocarcinoma
by: Macías-García Laura, et al.
Published: (2012-10-01)

Gastrointestinal Stromal Tumors: 10-Year Experience in Cancer Center—The Ottawa Hospital (TOH)
by: Abdulhameed Alfagih, et al.
Published: (2022-09-01)

Prospective Evaluation of Neoadjuvant Imatinib Use in Locally Advanced Gastrointestinal Stromal Tumors: Emphasis on the Optimal Duration of Neoadjuvant Imatinib Use, Safety, and Oncological Outcome
by: Shang-Yu Wang, et al.
Published: (2019-03-01)

Precision Oncology in Gastrointestinal Stromal Tumors
by: Hiba Mechahougui, et al.
Published: (2023-04-01)

Combined Inhibition of AKT and KIT Restores Expression of Programmed Cell Death 4 (PDCD4) in Gastrointestinal Stromal Tumor
by: Marya Kozinova, et al.
Published: (2021-07-01)

Advances in immunology and immunotherapy for mesenchymal gastrointestinal cancers
by: Bo Li, et al.
Published: (2023-04-01)

Unexpected reaction of “wild-type” gastrointestinal stromal tumor to imatinib: case report and literature review
by: Yang He, et al.
Published: (2024-01-01)

Rapidly progressive dyspnea in gastrointestinal stromal tumor (GIST) with imatinib cardiac toxicity
by: Adnan Asif Parvez Ghias, et al.
Published: (2018-03-01)

Gastric volvulus associated with shrinkage of a gastrointestinal stromal tumor by neoadjuvant imatinib: a case report
by: Yoichi Sugiyama, et al.
Published: (2023-01-01)

Characterization of a Human Gastrointestinal Stromal Tumor Cell Line Established by SV40LT-Mediated Immortalization
by: Xiangchen Hu, et al.
Published: (2023-09-01)

Type and Gene Location of <i>KIT</i> Mutations Predict Progression-Free Survival to First-Line Imatinib in Gastrointestinal Stromal Tumors: A Look into the Exon
by: Lorena Incorvaia, et al.
Published: (2021-02-01)

Preservation of Organ Function in Locally Advanced Non-Metastatic Gastrointestinal Stromal Tumors (GIST) of the Stomach by Neoadjuvant Imatinib Therapy
by: Nikolaos Vassos, et al.
Published: (2021-02-01)

Imatinib and hypophosphatemia: Case report and review of literature
by: Erdem Şen, et al.
Published: (2017-07-01)

Efficacy and safety of neoadjuvant imatinib therapy for patients with locally advanced rectal gastrointestinal stromal tumors: A multi-center cohort study
by: Weihao Li, et al.
Published: (2022-09-01)

Benefit of Continuation of Low-Dose Imatinib for Gastrointestinal Stromal Tumors despite Adverse Events with Regular-Dose Imatinib
by: Ryo Katsumata, et al.
Published: (2023-02-01)

Non-islet cell tumor-related hypoglycemia in a case of metastatic gastrointestinal stromal tumor: A rare paraneoplastic syndrome: A case report
by: Nalini Kanta Ghosh, et al.
Published: (2022-01-01)

Development and external validation of a nomogram for individualized adjuvant imatinib duration for high‐risk gastrointestinal stromal tumors: A multicenter retrospective cohort study
by: Ruolin Liu, et al.
Published: (2022-08-01)

<i>KIT</i> and <i>PDGFRA</i> Variants and the Survival of Patients with Gastrointestinal Stromal Tumor Treated with Adjuvant Imatinib
by: Heikki Joensuu
Published: (2023-07-01)

Measuring Tumour Imatinib Concentrations in Gastrointestinal Stromal Tumours: Relevant or Redundant?
by: Eline L. Giraud, et al.
Published: (2023-05-01)

Üst gastrointestinal sistem kanaması ile başvuran gastrik gastrointestinal stromal tümör olgusu
by: Doğan Nasır BİNİCİ, et al.
Published: (2017-03-01)

Mesenchymal stromal cells promote the drug resistance of gastrointestinal stromal tumors by activating the PI3K-AKT pathway via TGF-β2
by: Yu Zhao, et al.
Published: (2023-03-01)

Advanced gastrointestinal stromal tumor: reliable classification of imatinib plasma trough concentration via machine learning
by: Pan Ran, et al.
Published: (2024-02-01)

Ten Years of Treatment with 400 mg Imatinib per Day in a Case of Advanced Gastrointestinal Stromal Tumor
by: Silke Cameron, et al.
Published: (2011-10-01)

Epithelioid extragastrointestinal stromal tumor in the pelvic cavity: A rare case at a rare location
by: Divvay Vishvam, et al.
Published: (2023-01-01)

Changes in imatinib plasma trough level during long-term treatment in patients with intermediate- or high-risk gastrointestinal stromal tumors: Relationship between covariates and imatinib plasma trough level
by: Xingye Wu, et al.
Published: (2023-02-01)

Management of gastrointestinal stromal tumors: from diagnosis to treatment
by: JF Egger
Published: (2004-03-01)

Gastrointestinal Stromal Tumor Mimicking Ovarian Tumor
by: Özlem Seçilmiş Kerimoğlu, et al.
Published: (2012-12-01)